Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZQE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,782
Award facts
- Contract value 100% obligated
- $23,782.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23.78K delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of January 12, 2026, represents a child contract executed under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was awarded through full and open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order supports the Defense Logistics Agency's medical supply chain mission, which provides pharmaceutical products to military treatment facilities, veteran healthcare programs, and other federal medical institutions worldwide. AmerisourceBergen maintains a significant $999.99M indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which serves as the overarching vehicle enabling the company to supply a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support global military healthcare operations. The current award demonstrates the vendor's ongoing capability to fulfill federal pharmaceutical procurement requirements for critical medications.
Quick answers
Who was awarded contract SPE2DR26F4ZQE?
SPE2DR26F4ZQE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F4ZQE worth?
The government has obligated $23,782 on SPE2DR26F4ZQE.
Is contract SPE2DR26F4ZQE an order under another contract?
Yes. SPE2DR26F4ZQE is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZQE competed?
The extent of competition for SPE2DR26F4ZQE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award